PriceTargets.com logo

Healthcare Realty Trust - HR Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $17.20
  • Forecasted Upside: 23.21%
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 8 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$13.96 As of 04/19/2024 01:00 AM ET
▲ +0.17 (1.23%)

This chart shows the closing price for HR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Healthcare Realty Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HR

Analyst Price Target is $17.20
▲ +23.21% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Healthcare Realty Trust in the last 3 months. The average price target is $17.20, with a high forecast of $24.00 and a low forecast of $15.00. The average price target represents a 23.21% upside from the last price of $13.96.

This chart shows the closing price for HR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 10 contributing investment analysts is to hold stock in Healthcare Realty Trust. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/10/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$18.00 ➝ $15.00Low
3/6/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$19.00 ➝ $17.00Low
2/20/2024Stifel NicolausDowngradeBuy ➝ Hold$19.00 ➝ $15.00Low
2/20/2024WedbushDowngradeOutperform ➝ Neutral$19.00 ➝ $15.00Low
1/30/2024Deutsche Bank AktiengesellschaftInitiated CoverageHold$18.00Low
11/13/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$17.00 ➝ $16.00Low
11/6/2023WedbushReiterated RatingOutperform ➝ Outperform$17.00Low
10/24/2023BTIG ResearchUpgradeNeutral ➝ Buy$17.00Low
10/12/2023JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$19.00Low
10/10/2023ScotiabankLower TargetSector Perform ➝ Sector Perform$19.00 ➝ $17.00Low
10/10/2023Wells Fargo & CompanyLower Target$19.00 ➝ $17.00Low
10/6/2023BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$20.00 ➝ $17.00Low
10/3/2023WedbushInitiated CoverageOutperform$17.00Low
8/22/2023CitigroupLower TargetNeutral ➝ Neutral$19.00 ➝ $17.00Low
8/11/2023BarclaysLower TargetEqual Weight ➝ Equal Weight$25.00 ➝ $24.00Low
5/11/2023BarclaysBoost Target$24.00 ➝ $25.00Low
4/19/2023Wells Fargo & CompanyInitiated CoverageEqual WeightLow
3/29/2023BarclaysLower TargetOverweight$28.00 ➝ $24.00Low
3/6/2023Credit Suisse GroupDowngradeOutperform ➝ Neutral$23.00 ➝ $20.00Low
12/14/2022CitigroupDowngradeBuy ➝ Neutral$22.50 ➝ $22.00Low
12/2/2022JPMorgan Chase & Co.Lower TargetNeutral$28.00 ➝ $22.00Low
11/10/2022BarclaysLower Target$33.00 ➝ $28.00Low
9/19/2022CitigroupUpgradeNeutral ➝ Buy$27.00 ➝ $28.00Low
8/14/2022Capital One FinancialReiterated RatingOverweightLow
8/11/2022Sumitomo Mitsui Financial GroupUpgradeNeutral ➝ Outperform$30.00Low
8/9/2022CitigroupReiterated RatingNeutral$27.00Low
7/21/2022JPMorgan Chase & Co.Initiated CoverageNeutral ➝ NeutralLow
7/18/2022Credit Suisse GroupLower TargetOutperform$34.00 ➝ $29.00Low
6/22/2022BMO Capital MarketsInitiated CoverageHold$28.00Low
6/3/2022Capital One FinancialInitiated CoverageOverweight ➝ Overweight$33.00Low
5/10/2022Berenberg BankDowngradeBuy ➝ Hold$35.00 ➝ $32.00Low
4/26/2022BarclaysInitiated CoverageOverweight$33.00Low
2/1/2022Credit Suisse GroupInitiated CoverageOutperformMedium
1/7/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$34.00High
8/20/2021Raymond JamesDowngradeStrong-Buy ➝ Market PerformLow
7/29/2021Morgan StanleyBoost TargetEqual Weight$31.00 ➝ $33.00Low
3/31/2021Wells Fargo & CompanyBoost TargetEqual Weight$29.00 ➝ $31.00High
3/15/2021Morgan StanleyBoost TargetEqual Weight$30.00 ➝ $31.00High
1/28/2021ScotiabankInitiated CoverageSector Perform$32.00Medium
1/13/2021Jefferies Financial GroupUpgradeHold ➝ Buy$30.00 ➝ $33.00High
9/18/2020Capital One FinancialUpgradeEqual Weight ➝ Overweight$33.00High
9/1/2020Stifel NicolausReiterated RatingBuy$32.00Medium
8/31/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$34.00 ➝ $35.00Low
8/5/2020Capital One FinancialReiterated RatingEqual WeightLow
7/2/2020CitigroupBoost TargetNeutral$29.00 ➝ $30.00Low
4/29/2020Raymond JamesLower TargetOutperform$38.00 ➝ $34.00High
4/28/2020Wells Fargo & CompanyReiterated RatingHoldHigh
4/7/2020CitigroupDowngradeBuy ➝ Neutral$38.00 ➝ $29.00High
4/3/2020Wells Fargo & CompanyLower TargetEqual Weight$33.00 ➝ $26.00Low
4/3/2020JPMorgan Chase & Co.Lower TargetNeutral$35.00 ➝ $30.00Low
3/26/2020Morgan StanleyLower TargetEqual Weight$33.00 ➝ $25.00High
3/12/2020Raymond JamesBoost TargetOutperform$36.00 ➝ $38.00High
3/9/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$35.00 ➝ $43.00High
2/13/2020BMO Capital MarketsReiterated RatingHold$35.00Low
12/20/2019MizuhoReiterated RatingNeutral$34.00Medium
12/12/2019CitigroupUpgradeNeutral ➝ Buy$34.00 ➝ $38.00Medium
11/26/2019Stifel NicolausUpgradeHold ➝ Buy$33.00 ➝ $35.00High
11/6/2019BMO Capital MarketsReiterated RatingHold$31.00Low
9/17/2019Morgan StanleyBoost TargetEqual Weight$31.00 ➝ $33.00Low
9/12/2019Berenberg BankInitiated CoverageBuyLow
8/1/2019Capital One FinancialReiterated RatingEqual WeightLow
6/20/2019CitigroupInitiated CoverageNeutral ➝ Neutral$34.00Low
5/13/2019Raymond JamesUpgradeMkt Perform ➝ Outperform$34.00Medium
(Data available from 4/19/2019 forward)

News Sentiment Rating

1.31 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 18 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 8 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 19 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 26 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 24 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 13 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 13 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Healthcare Realty Trust logo
Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.
Read More

Today's Range

Now: $13.96
Low: $13.76
High: $14.03

50 Day Range

MA: $13.86
Low: $12.94
High: $15.76

52 Week Range

Now: $13.96
Low: $12.77
High: $20.32

Volume

2,211,452 shs

Average Volume

3,188,169 shs

Market Capitalization

$5.32 billion

P/E Ratio

N/A

Dividend Yield

9.03%

Beta

0.79

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthcare Realty Trust?

The following Wall Street analysts have issued research reports on Healthcare Realty Trust in the last twelve months: Barclays PLC, BMO Capital Markets, BTIG Research, Citigroup Inc., Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Scotiabank, Stifel Nicolaus, StockNews.com, Wedbush, and Wells Fargo & Company.
View the latest analyst ratings for HR.

What is the current price target for Healthcare Realty Trust?

10 Wall Street analysts have set twelve-month price targets for Healthcare Realty Trust in the last year. Their average twelve-month price target is $17.20, suggesting a possible upside of 23.2%. Barclays PLC has the highest price target set, predicting HR will reach $24.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $15.00 for Healthcare Realty Trust in the next year.
View the latest price targets for HR.

What is the current consensus analyst rating for Healthcare Realty Trust?

Healthcare Realty Trust currently has 8 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HR, but not buy more shares or sell existing shares.
View the latest ratings for HR.

What other companies compete with Healthcare Realty Trust?

Other companies that are similar to Healthcare Realty Trust include Ryman Hospitality Properties, Sabra Health Care REIT, Omega Healthcare Investors, EPR Properties and Medical Properties Trust. Learn More about companies similar to Healthcare Realty Trust.

How do I contact Healthcare Realty Trust's investor relations team?

Healthcare Realty Trust's physical mailing address is 3310 WEST END AVE SUITE 700, NASHVILLE TN, 37203. The real estate investment trust's listed phone number is (615) 269-8175 and its investor relations email address is [email protected]. The official website for Healthcare Realty Trust is www.healthcarerealty.com. Learn More about contacing Healthcare Realty Trust investor relations.